Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase III randomized trial.

Wedemeyer H, Aleman S, Brunetto M, Blank A, Andreone P, Bogomolov P, Chulanov V, Mamonova N, Geyvandova N, Morozov V, Sagalova O, Stepanova T, Berger A, Ciesek S, Manuilov D, Mercier RC, Da BL, Chee GM, Li M, Flaherty JF, Lau AH, Osinusi A, Schulze Zur Wiesch J, Cornberg M, Zeuzem S, Lampertico P

Open source

DOI: 10.1016/j.jhep.2024.05.001
Published: 2024 Oct
Container: Journal of hepatology
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jhep.2024.05.001,
  title = {Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase III randomized trial.},
  author = {Wedemeyer H and Aleman S and Brunetto M and Blank A and Andreone P and Bogomolov P and Chulanov V and Mamonova N and Geyvandova N and Morozov V and Sagalova O and Stepanova T and Berger A and Ciesek S and Manuilov D and Mercier RC and Da BL and Chee GM and Li M and Flaherty JF and Lau AH and Osinusi A and Schulze Zur Wiesch J and Cornberg M and Zeuzem S and Lampertico P},
  year = {2024},
  journal = {Journal of hepatology},
  doi = {10.1016/j.jhep.2024.05.001},
  url = {https://doi.org/10.1016/j.jhep.2024.05.001}
}

RIS

TY  - JOUR
TI  - Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase III randomized trial.
AU  - Wedemeyer H
AU  - Aleman S
AU  - Brunetto M
AU  - Blank A
AU  - Andreone P
AU  - Bogomolov P
AU  - Chulanov V
AU  - Mamonova N
AU  - Geyvandova N
AU  - Morozov V
AU  - Sagalova O
AU  - Stepanova T
AU  - Berger A
AU  - Ciesek S
AU  - Manuilov D
AU  - Mercier RC
AU  - Da BL
AU  - Chee GM
AU  - Li M
AU  - Flaherty JF
AU  - Lau AH
AU  - Osinusi A
AU  - Schulze Zur Wiesch J
AU  - Cornberg M
AU  - Zeuzem S
AU  - Lampertico P
PY  - 2024
JO  - Journal of hepatology
DO  - 10.1016/j.jhep.2024.05.001
UR  - https://doi.org/10.1016/j.jhep.2024.05.001
ER  -

APA

H, W., S, A., M, B., A, B., P, A., P, B., V, C., N, M., N, G., V, M., O, S., T, S., A, B., S, C., D, M., RC, M., BL, D., GM, C., M, L., JF, F., AH, L., A, O., J, S. Z. W., M, C., S, Z., & P, L. (2024). Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase III randomized trial.. Journal of hepatology. https://doi.org/10.1016/j.jhep.2024.05.001

Source records

pubmed · retrieved 2026-09-27T13:11:02.290Z
europe-pmc · retrieved 2026-09-27T13:11:02.301Z